There is now overwhelming evidence to support lowering LDL-c (low-density lipoprotein
cholesterol) to reduce cardiovascular morbidity and mortality. Statins are a class of drugs …

Abstract Treatment with statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A
reductase, has proven beneficial preventive effects on cardiovascular events. However …

Statins represent the cornerstone of pharmacotherapy for the prevention of atherosclerotic
cardiovascular disease. These medications not only reduce low-density lipoprotein …

Statins are a cornerstone in the pharmacological prevention of cardiovascular disease.
Although generally well tolerated, a small subset of patients experience statin-related …

ABSTRACT Introduction: Adverse drug reactions (ADRs) are a major health concern
worldwide. There are multiple causes of ADRs, some of which are preventable …

Most of the current non‐pharmacological treatment strategies for atherosclerosis (AS) suffer
from poor penetration into the plaque and only aim at a certain factor in its formation …

Spatial and temporal precisely control of direction and speed is crucial for nanomotors to
enable complex operations and applications in microsurgery, drug delivery, isolation of …

Statins, a class of lipid-lowering medications, have been a keystone treatment in
cardiovascular health. However, adverse effects associated with statin use impact patient …

Most of the prescribing and dispensing of medicines happens in primary care.
Pharmacogenomics (PGx) is the study and clinical application of the role of genetic variation …

Statin therapy reduces cardiovascular events in patients with, or at risk of, atherosclerotic
cardiovascular disease. However, statins are underutilized in patients for whom they are …